Windlas Biotech Ltd. IPO

It is among the top 5 companies in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry.

Company Financials

You can get the following financial statements of Windlas Biotech Ltd. as of now.

The valuation of Windlas Biotech IPO company based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 460
Existing Shares (Qty) 1.82 Cr
Fresh Issue (Qty)  0.36 Cr
Market Cap ~1003 Cr
EPS  Rs 8.7 
PE Ratio ~53x
Industry PE ~13x

 

Windlas Biotech IPO issue size is 401.54 Cr

Issue Amount
Fresh Issue 165 Cr
Offer For Sale 236.54 Cr

 

An Individual can apply for a minimum 1 lot of 30 shares and a maximum of 14 lots of 420 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 30 Rs 13,800
 Maximum 14 420 Rs 1,93,200

 

Windlas Biotech IPO is subscribed 22.44 times till 6th August. It is Oversubscribed as of now. The category-wise subscription is as follows:

Category % Offered Subscription 
Qualified Institutional Maximum 50% 24.40 Times
Non-Institutional Minimum 15% 15.73 Times
Retail Individual Minimum 35% 24.22 Times
Total   22.44 Times

Once you have subscribed to an IPO, you have to wait for its allotment to your account. Find below the dates of allotment of Windlas Biotech IPO:

Schedule Date
Basis of Allotment 11 August 2021
Refunds 12 August 2021
Credit to Demat Account 13 August 2021
IPO Listing Date 16 August 2021

 

When the allotment is out, you can check it from the registrar's website. Find the Windlas Biotech IPO allotment status here.

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 427.6 465.93 513.08 630.96 759.88
Total Expenditure 372.91 413.04 452.84 552.85 665.76
Operating Profit 54.69 52.9 60.24 78.1 94.12
Other Income 3.09 6.71 9.97 13.47 17.65
Interest 1.29 1.42 0.79 1.1 4.38
Depreciation 12.97 12.15 12.36 13.44 27.99
Exceptional Items -32.35 0 0 0 0
Profit Before Tax 11.18 46.04 57.06 77.02 79.39
Provision for Tax 6.17 7.48 14.41 18.88 18.75
Net Profit 5.01 38.56 42.64 58.14 60.65
Adjusted EPS (Rs.) 0.28 1.77 2.04 2.8 2.89

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 6.41 10.9 10.46 10.4 10.48
Total Reserves 192.58 384.23 392.2 439.89 495.31
Borrowings 0.83 0.44 0.11 0 0
Other N/C liabilities 2.75 -0.23 3.33 3.95 4.95
Current liabilities 93.42 93.65 120.88 171.35 249.42
Total Liabilities 295.99 488.99 526.98 625.59 760.16
Assets
Net Block 95.94 91.18 109.41 179.05 223.39
Capital WIP 0.04 7.58 13.8 5.71 3.2
Intangible WIP 0 0.43 0.98 0 2.12
Investments 0.03 0.03 0.03 0 0
Loans & Advances 5.84 5.39 43.31 7.54 5.22
Other N/C Assets 0 2.73 5.92 2.05 1.12
Current Assets 194.15 381.63 353.54 431.24 525.13
Total Assets 295.99 488.99 526.98 625.59 760.16
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Other Income 4.44 4.13 4.84 3.73 4.94
Profit Before Tax 22.56 18.31 20.29 19.97 20.83
Tax 5.61 4.83 4.63 4.74 4.54
Profit After Tax 16.95 13.48 15.66 15.23 16.29
Adjusted EPS (Rs) 8.15 6.45 7.49 7.29 7.77

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 62.34 0
Mar 2025 62.34 0
Dec 2024 62.51 0
Sep 2024 62.51 0
Jun 2024 62.51 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 11.18 46.04 57.06 77.02 79.39
Adjustment 46.85 9.75 7.35 6.6 18.41
Changes in Assets & Liabilities -40.05 -37.91 6.29 43.91 -8.71
Tax Paid -6.53 -8.88 -9.72 -18.62 -20.87
Operating Cash Flow 11.45 9 60.98 108.91 68.23
Investing Cash Flow -14.53 -154.31 -14.11 -92.07 -74.06
Financing Cash Flow 0.78 130.09 -43.74 -15.29 1.01
Net Cash Flow -2.3 -15.22 3.13 1.56 -4.82
X